Mark William Lowdell, Chief Scientific Officer, 10% Owner at Inmune Bio, Inc. (INMB), bought 2,918 shares at $6.23 ($18K) on 2019-09-11, disclosed to the SEC on 2019-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| INMB | SELL | 2021-10-29 | $47K | — | Filing → |
| INMB | SELL | 2021-10-26 | $8K | — | Filing → |
| INMB | SELL | 2021-07-09 | $1.1M | — | Filing → |